Many studies reported that HDAC1 is overexpressed in prostate, colon adenocarcinoma gastric, and breast carcinomas [102,103,104,105], whereas HDAC2 is overexpressed in colorectal [106], cervical [107], and gastric cancers [108]. This evidence concerns the gene HDAC2 and breast carcinoma.